health
What RevMed’s pancreatic cancer drug meant for one patient
Why this matters: health reporting relevant to everyday decisions and well-being.
Why did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."
Read full story on STAT News → More top storiesAlso covered by
Healthline
Groundbreaking New Drug Nearly Doubles Pancreatic Cancer Survival
ABC Australia
Man accused of stealing $10K from 83yo cancer patient outside bank
ABC Australia
Life-saving breast cancer and endometriosis drug to be discontinued
Investing.com
Leerink raises Nanobiotix stock price target on cancer drug data
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop